LEGACY Overview
- Headquarters
- Amsterdam, Noord-holland, Nl
- Industry
- Research Services
- Employees
- 31
- Founded
- 2022
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
About LEGACY
An open-label, multicenter, randomized controlled trial in the Netherlands that evaluates whether completely omitting aspirin after PCI in non-ST-segment elevation acute coronary syndrome patients is superior to DAPT in terms of major or minor bleeding and non-inferior to DAPT in terms of ischemic events.